Hualan Biological Vaccine Inc. engages in the research, development, production, and sale of vaccines in China. It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, influenza A (H1N1) virus split vaccines, ACYW135 group meningococcal polysaccharide vaccines, recombinant hepatitis B vaccines, group A and C meningococcal polysaccharide vaccines, freeze-dried human rabies vaccine, and tetanus vaccines, as well as genetic engineering of biological products. The company also sells self-produced products. The company was founded in 2005 and is based in Xinxiang, China.
Metrics to compare | 301207 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship301207PeersSector | |
---|---|---|---|---|
P/E Ratio | 50.5x | 30.3x | −0.5x | |
PEG Ratio | −0.67 | −0.80 | 0.00 | |
Price/Book | 1.7x | 2.4x | 2.6x | |
Price / LTM Sales | 9.0x | 6.5x | 3.1x | |
Upside (Analyst Target) | 45.7% | 18.2% | 47.8% | |
Fair Value Upside | Unlock | 18.1% | 6.9% | Unlock |